| Immunocompromised | Immunocompetents | |
| n(%) | 84(44) | 107(56) |
| Age(X±SD) | 60.94±17.14 | 63.14±18.31 |
| Males(%) | 66.7 | 51.4∗ |
| Patients with comorbidities[n(%)] | 84(100) | 94(87.9) |
| Previous pneumonia | 39.3 | 9.6∗ |
| Chronic liver disease | 27.4 | 17 |
| COPD/Asthma | 23.9 | 29.8 |
| Diabetes mellitus | 11.9 | 23.4 |
| Clinical presentation(%) | ||
| Pneumonia | 63 | 77.5 |
| Meningitis | 7.1 | 12.1 |
| Primary bacteremia | 14.3 | 1.9∗ |
| Sepsis | 8.3 | 1.9 |
| Peritonitis | 3.6 | 4.7 |
| Health care-associated IPD(%) | 17.9 | 5.6∗ |
| Mortality(%) | 19 | 9.3 |
| PPV23 vaccination | 25 | 19.6 |
| PCV13 Sts(%) | 38.1 | 64.4 |
| 6C(%) | 6 | 5.6 |
| PPV23nonPCV13 Sts(%) | 26.1 | 12.1 |
| Other Sts(%) | 35.7 | 23.3 |
∗p<0.05